Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q4 2021 call → NOThe question asks whether management's account of the reported period is built around real business activity that crossed from not-happening to happening partway through the period, and whether management makes clear that this newly started activity is still completing its climb, so the period's reported numbers averaged the 'before' and 'after' and therefore sit below the level at which the business is already running. Let me examine the transcript for evidence of such a phenomenon. Key elements to look for: 1. A concrete business activity that genuinely BEGAN during or immediately around the reported period (Q4 2021 / full year 2021) 2. Management describes it as a start, in the language of crossing over 3. The climb is incomplete - the reported results captured only a partial slice 4. The business is exiting the period at a higher level than the period's figures show 5. The remaining climb is a matter of the already-started activity continuing and filling out Let me scan the transcript: - HETLIOZ: "we continue to see strong interest with new patient prescriptions, especially for sighted patients with Non-24. However, we also saw a significant increase in the rates of payer denial for sighted patients with Non-24 that led to a net decline of Non-24 patients in treatment." This is about payer challenges, not a new start. - HETLIOZ for Smith-Magenis Syndrome (SMS): "We launched HETLIOZ and HETLIOZ LQ for the indication of night-time sleep disturbances in patients with Smith-Magenis Syndrome. More than 50 patients with SMS are currently on treatment and more are awaiting payer approval." This is a launch. But is it described as a start that crossed from not-happening to happening partway through the period? The launch is mentioned, but the transcript doesn't clearly indicate when in the period this launch occurred, nor does it describe the reported numbers as averaging before and after, nor does it describe the climb as incomplete with the business exiting at a higher level. - The tradipitant gastroparesis study: This is a clinical trial result, not a business activity that started generating revenue. - The payer challenges with Medicaid: "In November of last year, a HETLIOZ patient filed a federal lawsuit challenging Colorado Medicaid's prior authorization criteria... In response to this lawsuit, Colorado promptly changed its criteria...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.